Current status of newer generation endoscopic ultrasound core needles in the diagnostic evaluation of gastrointestinal lesions.
Autoimmune Pancreatitis
/ diagnostic imaging
Endoscopic Ultrasound-Guided Fine Needle Aspiration
/ instrumentation
Gastrointestinal Neoplasms
/ diagnostic imaging
Gastrointestinal Tract
/ pathology
Humans
Lymph Nodes
/ diagnostic imaging
Lymphoma
/ diagnostic imaging
Needles
/ classification
Pancreas
/ diagnostic imaging
Pancreatic Neoplasms
/ diagnostic imaging
EUS- FNA
Endoscopic ultrasound
Fine-needle aspiration
Fine-needle biopsy
Pancreatic cytology
Rapid onsite specimen evaluation (ROSE)
Journal
Journal of the American Society of Cytopathology
ISSN: 2213-2945
Titre abrégé: J Am Soc Cytopathol
Pays: United States
ID NLM: 101613234
Informations de publication
Date de publication:
Historique:
received:
07
04
2020
revised:
11
05
2020
accepted:
12
05
2020
pubmed:
19
7
2020
medline:
28
8
2021
entrez:
19
7
2020
Statut:
ppublish
Résumé
Endoscopic ultrasound-guided tissue acquisition is now an imperative technique for the diagnosis of multiple diseases in the gastrointestinal tract and nearby structures. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and fine needle biopsy via dedicated FNB needles (EUS-FNB) are two standard-essential tools for tissue acquisition. The choice of needle type is an important factor determining appropriate tissue acquisition. Multiple studies have compared EUS-FNA versus EUS-FNB on different lesions also there are several studies evaluated different needles in terms of sampling adequacy and cytological and histological accuracy. Prior studies comparing prior-generation FNB needles to FNA did not show an increased diagnostic yield with FNB. However, the newer-generation needles have demonstrated enhanced performance compared with their predecessors. As they may provide a large amount of tissue for the cytological and histological evaluation, rapid onsite specimen evaluation (ROSE), and immunohistochemical and molecular analyses, which may be very important for targeted therapy. In this review, we discuss current evidence and literature on the use of the newer generation needles for pancreatic and non-pancreatic lesions.
Identifiants
pubmed: 32680792
pii: S2213-2945(20)30087-9
doi: 10.1016/j.jasc.2020.05.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
389-395Informations de copyright
Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.